This Solicitation opportunity from Department Of Defense was posted on August 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GLOBULIN, RHO (D) IMMUN

Closed

SPE2DP-26-T-4572Federal

Submission Closed08/17/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

SLED

Drug Testing Kit and Reagent SupplierThis subcontract agreement establishes a partnership for the supply of drug testing kits and reagents to support prime contractors working on MPTAP projects for the Board of Supervisors of Leake County, Mississippi. The supplier is responsible for providing consumables, including specific kits for drug metabolites such as Fentanyl and Kratom, as well as 5m x 75m plastic tubes. To ensure operational efficiency, all provided kits must be fully compatible with the existing installed analyzer. The contract requires the capacity to support a high volume of testing, estimated between 8,000 and 10,000 tests per month, with deliverables managed through monthly shipments. This procurement falls under NAICS code 325412 and is managed by the state of Mississippi.

POSTED

DEADLINE

Lenalidomide Medication SupplyThis subcontract involves the supply of Lenalidomide oral capsules in various dosage strengths ranging from 2.5mg to 25mg to support prime contractors on Department of Veterans Affairs pharmaceutical procurement projects. The selected provider is responsible for manufacturing or distributing the medication in the requested formulations and quantities, ensuring all products adhere to FDA standards for purity and dosage. A critical requirement for this contract is the mandatory FDA Risk Evaluation and Mitigation Strategy certification. Deliveries are organized by specific contract line item numbers 0001 through 0006. The opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 with a response deadline of November 12, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of Self-Locking Nuts (NSN 7540-01-152-8070)This subcontract involves the procurement and delivery of specialized self-locking nuts, identified by NSN 7540-01-152-8070, to support prime contractors working on NAVSUP Weapon Systems Support projects for the Department of Defense. The scope of work focuses on the physical supply of these hardware components, with shipping conducted under F.O.B. Destination terms to ensure delivery to the designated location. The agreement requires strict adherence to federal regulations, specifically FAR Clauses 52.222-20 and 52.222-50. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 12, 2026.

Navsup Weapon Systems Support Mech

POSTED

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--FY27 Lenalidomide BPA

Solicitation # 36C26227Q0083

The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supplier of Critical Application Electrical Insulation TapeThis subcontract, issued by the Department of Defense under the DLA Weapons Support Nuclear Reactor Program, seeks a supplier for critical application grade electrical insulation tape. The required material must meet NSN 5970-00-284-8565 specifications, featuring a nominal width of 0.750 inches, a thickness of 0.0070 inches, and a delivery format of 180 foot rolls. To ensure quality and longevity, the tape must maintain a minimum shelf life of 18 months in accordance with Shelf-Life Code 5. The project is categorized under NAICS code 325412 and will be performed at Hurlbert Field. Interested parties must submit their responses by November 9, 2026, to support prime contractors working on specialized defense projects.

DLA WEAPONS SUPPORT NUCLEAR REACTOR PROGRAM

POSTED

DEADLINE

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the manufacture and supply of Bupivacaine HCl and Epinephrine pharmaceutical anesthetic injections for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The scope of work requires the production of 1.8 ML cartridges with a concentration of 0.500 PCT W/V and 0.005 MG/ML, packaged in units of 50. The total delivery requirement is for 1,000 CN of injection cartridges. To ensure product viability and safety, the supplier must guarantee a minimum remaining shelf life of 15 months upon delivery. All products must strictly adhere to FDA compliance and DLA Medical Supply Chain quality standards. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Simethicone Tablets (USP) SupplyThis subcontract involves the supply of Simethicone Tablets, USP, 80 MG, Chewable, for prime contractors delivering to the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for manufacturing or sourcing the tablets according to USP standards, ensuring they are produced in FDA-approved facilities. The product must be delivered in unit dose 100-count blister packs with a minimum shelf life of 36 months and must adhere to Medical Marking Standard No. 1. The contract is categorized under NAICS code 325412 and is associated with a performance location in Washington. Interested parties should note the response deadline of November 4, 2026, for this procurement effort.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Casualty Triage Tags (NSN 6515015871700)This subcontract involves the manufacture and supply of combat casualty triage tags under NSN 6515015871700 for prime contractors supporting DLA Troop Support medical supply contracts. The tags must be produced using waterproof and tear-resistant ruggedized paper and delivered in packages of 25. The Department of Defense requires strict adherence to specific packaging and marking standards, including ASTM D3951, MIL-STD-129, and Medical Marking Standard No. 1. The contractor is required to comply with RD003 Covered Defense Information requirements to ensure data security. Performance for this contract is designated for FPO 09595-2200, falling under NAICS code 325412. The procurement is managed by the Medical Supply Chain MD Surg FSF within the Department of Defense.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Hexagon Plain Nuts with Extended WashersThis subcontract involves the sourcing or manufacture of a specific industrial fastener, identified as a Hexagon Plain Nut with an Extended Washer under NSN 5310015987463. The contractor is responsible for ensuring the component meets all technical specifications and delivering one unit to the DLA location at Fort Bliss, Texas. This effort supports prime contractors operating within the Department of Defense DLA Weapons Support Aviation Supply Chain. Eligible bidders must possess a valid CAGE code and Unique Entity Identifier to participate. The solicitation was posted on October 29, 2026, with a response deadline of November 6, 2026. The project falls under NAICS code 325412 and is managed by the DLA Weapons Support Aviation Supply Chain ESOC Buys.

DLA WEAPONS SUPPORT AVIATION SUPPLY CHAIN ESOC BUYS

POSTED

DEADLINE

Supply of Loratadine Tablets 10 MGThis subcontract involves the supply of pharmaceutical-grade Loratadine 10 MG tablets, identified by NSN 6505-01-524-9179, to prime contractors supporting the Department of Defense Medical Supply Chain. The tablets must be packaged in bottles of 500 units and maintain a non-extendable shelf life of 36 months. To ensure product integrity, the contract mandates strict climate-controlled storage and transport conditions, requiring temperatures to be held between 20 to 25 degrees Celsius and protection from moisture. The performance of this contract is centered at Camp Pendleton, California. Interested parties must adhere to the timeline associated with the solicitation, which was posted on October 29, 2026, with a response deadline of November 4, 2026. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

The contract solicitation is for GLOBULIN RHO (D) IMMUNE, USP, 300 MCG in 1 mL pre-filled disposable syringes with safety features, to be administered intramuscularly, with a unit of issue of each. The product is regulated by the FDA, requires a prescription for dispensing, and must be stored between 2-8 degrees Celsius without freezing. The item has a non-extendable shelf life of 24 months and is subject to strict packaging, marking, and handling requirements under DLA Master List of Technical and Quality Requirements, MIL-STD-129, ASTM D3951, and federal hazardous materials regulations including 49 CFR, ICAO Technical Instructions, and IMDG Code. The item is classified as hazardous, necessitating a current Material Safety Data Sheet (MSDS) to be submitted prior to award and included with each shipment, along with compliant hazard warning labels aligned with the Hazard Communication Standard (29 CFR 1910.1200), unless exempted by other federal acts such as the Federal Food, Drug and Cosmetics Act. Packaging must adhere to RP001 DLA packaging standards and palletization guidelines, and all containers must be properly marked per Medical Marking Standard No. 1 and FED-STD-313. Delivery is required within 20 days after the order date, with FOB Destination terms, and the delivery point is designated as FPO. The solicitation, numbered SPE2DP-26-T-4572, issued on August 9, 2026, with a response deadline of August 17, 2026, is for two units and is not a small business set-aside. Offers must be submitted electronically via the DIBBS portal, and failure to provide the MSDS or hazard labels before award renders the offeror nonresponsible. The contract incorporates extensive FAR and DFARS clauses related to cybersecurity, information safeguarding, whistleblower rights, export controls, supplier performance risk, prohibition of covered defense equipment, and compliance with NIST SP 800-171 DOD assessment requirements. Payment must be processed electronically through WAWF, with no fast pay option available. The contracting officer is James Foggie of the DLA Troop Support Medical Supply Chain Pharm FSA, and the solicitation contemplates award of a contract type to be determined. The offeror must

General Info

GLOBULIN RHO (D) 300 mcg/mL intramuscular injection, stored 2–8°C, 2 units ordered, delivery in 20 days, hazardous material, FDA-regulated.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100206 BOX 1, FPO, AP, 96666, USA

Set-Aside

NONE

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 9

Solicitation

Response DeadlineAug 17

Deadline has passed

Submission Closed

08/17/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

JAMES FOGGIE

contact@example.gov

+1 (555) 000-0000

Full Description

GLOBULIN,RHO (D) IMMUNE
GLOBULIN<(>,<)> RHO (D) IMMUNE, USP, 300 MCG, 1'S. 300 MICROGRAMS; ADULT
DOSE; DISPOSABLE; 1ML SYRINGE WITH SAFETY; INJECT ONLY INTRAMUSCULARLY;
UNIT OF ISSUE "EACH. STORE AT 2-8 DEG.C; DO NOT FREEZE; DISPENSE
BYPRESCRIPTION ONLY.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RQ034: HAZARDOUS COMMUNICATION STANDARD NOTICE
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
contact@example.gov.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.,
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-417-1250 Quantity: 2 EA Purchase Request: 7017787207QTY: 2 Delivery: 20 days ADO